clinical drug trial Flashcards

0
Q

Which phase most commonly used healthy subjects?

A

Phase 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Out of phases 1-4 which phase of drug trials are double-blind?

A

Phase 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which phase determines response and dosing regiment?

A

Phase 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which phase focuses on long term risks and benefits?

A

Phase 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which phase provides adequate basis for extrapolating results to the general population?

A

3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which phase is intended to establish safety and tolerability?

A

Phase 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which phase determines that effectiveness of a drug for a certain disease?

A

Phase 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How can you prevent subject/participant bias?

A

Placebo use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How can you prevent observer bias?

A

Blinding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How can you prevent selection bias?

A

Randomizing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When the sponsor submits preclinical research data to the FDA to proceed with human clinical trials this is what?

A

Investigational new drug application

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What board ensures the rights and welfare of clinical trial participants before and during the trial?

A

The institutional review board (IRB)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When a sponsor formally proposes that the FDA approve a new drug for sale in the US

A

New drug application

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Reviews safety and efficacy data on an interim basis?

A

The data and safety monitoring board

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Accelerated development and approval for serious life-threatening disease

A

Fast track status

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

For a disease the effects <200,000 pts in the US, 7 yrs exclusivity patent

A

Orphan drug

16
Q

Meds in phase 3 development–gives access to patients who may not survive

A

Compassionate use

17
Q

True or false. Generic drugs have to undergo an approval process identical to that of the innovator drug

A

False

18
Q

Generic drugs must meet the same batch requirements for identity, strength, purity, and quality as the innovator drug

A

True

19
Q

Generic drugs are more expensive and more effective than their innovator counterparts

A

False

20
Q

Generic drugs must have the same what ingredients as the innovator drug?

A

Active

21
Q

A generic drug must be bio equivalent to the innovator drug. This means it must have the same what 4 things?

A

Absorption, distribution, metabolism, and excretion

22
Q

What is the goal of med watch? Who can report adverse events to the spontaneous adverse events reporting system?

A

To capture serious adverse events, anyone